NCM · Medical - Healthcare Information Services

Heartbeam, Inc. (BEAT) Stock

$0.39 -1.21% NCM: BEAT Healthcare

Valuation

MetricValue
Price$0.39
Market Cap$22.16M
P/E Ratio-0.84
P/B Ratio2.80
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$4.00
52-Week Low$0.35
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-686.78%
ROA-190.81%
ROCE-249.58%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio1.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-13.0M$-15.0M$-20.0M$-21.0M
Net Profit$-4.0M$-13.0M$-15.0M$-19.0M$-21.0M
EPS$-0.56$-1.59$-0.72$-0.73$-0.62
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.0M$4.0M$17.0M$3.0M$6.0M
Total Liabilities$1.0M$2.0M$1.0M$2.0M$3.0M
Cash$13.0M$4.0M$16.0M$2.0M$4.0M
Borrowings$0$0$0$0$0

Latest News

HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device Business Wire · Jul 14, 2026 HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital NewMediaWire · Jul 1, 2026 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule Business Wire · Jul 1, 2026 HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study NewMediaWire · Jun 30, 2026 HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp Simply Wall St. · Jun 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-10.0M$-12.0M$-14.0M$-14.0M
Investing Cash Flow$0$0$-1.0M$0$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$13.0M$-10.0M$13.0M$-14.0M$2.0M
Free Cash Flow$-3.0M$-10.0M$-12.0M$-15.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-0.76
FCF Yield-58.08%
Quick Ratio3.61
Interest Coverage—
Return 1Y-47.19%
Return 3Y-79.44%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRVOCervoMed Inc. $2.31 +3.13% -0.94 $34.93M 0.00%
EQEquillium, Inc. $1.23 -3.15% -5.50 $77.99M 0.00%
HOWLWerewolf Therapeutics, Inc. $0.98 -2.96% -1.26 $47.63M 0.00%
INKTMiNK Therapeutics, Inc. $10.71 +6.46% -4.33 $54.65M 0.00%
IOBTIO Biotech, Inc. $0.01 -27.59% -0.01 $885690 0.00%

About Heartbeam, Inc.

Heartbeam, Inc. is led by CEO Robert Eno, publicly traded since 2021.

Heartbeam, Inc. (BEAT) stock trades at $0.39 with a market capitalization of $22.16M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.84, reflecting a net loss over the last twelve months, price-to-book of 2.80, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.35 and $4.00, and currently trades 90.3% below its 52-week high.

On profitability, Heartbeam, Inc. generates a return on equity (ROE) of -686.78% (negative, reflecting a net loss), return on capital employed of -249.58%.

Heartbeam, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Heartbeam, Inc. reported revenue of $208.0M rising to $0, a change of -100.0% across 10 years. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-21.0M.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-20.0M.

Borrowings fell from $25.0M to $0, cash from operations was $-14.0M in the latest year, positive in 3 of the last 10.

Return on equity has averaged -484.9% over five years, and was -700.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Heartbeam, Inc. (BEAT) — frequently asked questions

What is Heartbeam, Inc. (BEAT) stock price today?

Heartbeam, Inc. (BEAT) is currently trading at $0.39, down 1.21% today.

What is BEAT P/E ratio?

Heartbeam, Inc.'s P/E ratio is -0.84. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is BEAT return on equity (ROE)?

Heartbeam, Inc.'s return on equity (ROE) is -686.78%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Heartbeam, Inc.'s market cap?

Heartbeam, Inc. has a market capitalization of $22.16M.

Does BEAT pay a dividend?

Heartbeam, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does BEAT carry?

Heartbeam, Inc. has a debt-to-equity ratio of 0.00. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is BEAT's profit margin?

Heartbeam, Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.

What sector is BEAT in?

Heartbeam, Inc. is classified under Healthcare, in the Medical - Healthcare Information Services industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is BEAT listed on?

Heartbeam, Inc. trades on NCM under the ticker BEAT.

What is BEAT's 52-week range?

Over the last year Heartbeam, Inc. has traded between $0.35 and $4.00.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens BEAT currently matches

On the figures above, Heartbeam, Inc. passes the filters for 4 of our ready-made screens, among them Penny Stocks, Stocks Under $1, Debt Free Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksStocks Under $1Debt Free Stocks Under $100Nano Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.